l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide has been researched along with thyroxine in 2 studies
| Studies (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Trials (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Recent Studies (post-2010) (l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide) | Studies (thyroxine) | Trials (thyroxine) | Recent Studies (post-2010) (thyroxine) |
|---|---|---|---|---|---|
| 138 | 7 | 2 | 38,989 | 1,410 | 6,550 |
| Protein | Taxonomy | l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide (IC50) | thyroxine (IC50) |
|---|---|---|---|
| Transthyretin | Homo sapiens (human) | 2.1939 | |
| UDP-glucuronosyltransferase 1A1 | Homo sapiens (human) | 5.25 | |
| Solute carrier organic anion transporter family member 4C1 | Homo sapiens (human) | 8 | |
| Bile acid receptor | Homo sapiens (human) | 7.86 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckland, DJ; Guiloff, RJ; Lightman, SL; Modarres-Sadeghi, H | 1 |
| Eckland, DJ; Lightman, SL | 1 |
1 trial(s) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and thyroxine
| Article | Year |
|---|---|
The TSH, T4, T3 and prolactin responses to consecutive infusions of a potent and stabilized thyrotrophin releasing hormone analogue, RX77368, in man.
Topics: Adult; Central Nervous System; Humans; Male; Prolactin; Pyrrolidonecarboxylic Acid; Receptors, Neurotransmitter; Receptors, Thyrotropin-Releasing Hormone; Thyroid Hormones; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1988 |
1 other study(ies) available for l-pyroglutamyl-l-histidyl-3,3-dimethylprolinamide and thyroxine
| Article | Year |
|---|---|
The effects of repeated administration of a long acting TRH analogue (RX77368), on TSH, T4, T3 and prolactin in patients with motor neuron disease.
Topics: Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Motor Neurons; Neuromuscular Diseases; Prolactin; Pyrrolidonecarboxylic Acid; Thyrotropin; Thyrotropin-Releasing Hormone; Thyroxine; Triiodothyronine | 1990 |